|
|
|
|
123 * !
|
Mon, 8/9/2021,
1:30 PM -
3:20 PM
|
Virtual
|
|
Innovative Designs for Benefit of Patients — Topic-Contributed Papers
|
|
Biopharmaceutical Section, Biometrics Section
|
|
Organizer(s): Rong Liu, Bristol Myers Squibb
|
|
Chair(s): Cristiana Mayer, Janssen R&D
|
|
1:35 PM
|
Adaptive Endpoints Selection with Application in Rare Disease
Heng Xu, Nektar Therapeutics; Yi Liu, Nektar Therapeutic; Robert Allen Beckman, Georgetown University Medical Center
|
|
1:55 PM
|
Master Protocols and Their Benefits for Clinical Trial Participants and Patients
Robert Allen Beckman, Georgetown University Medical Center
|
|
2:15 PM
|
A Roadmap to Using Historical Controls in Clinical Trials, by Drug Information Association Innovative Design Scientific Working Group
Mercedeh Ghadessi, Bayer Pharamceuticals
|
|
2:35 PM
|
Ethics: Patients, Research Subjects, and Drug Development
Gianna McMillan, Loyola Marymount University Bioethics Institute
|
|
2:55 PM
|
Discussant: Zoran Antonijevic, MedSource
|
|
3:15 PM
|
Floor Discussion
|
